chrisvoncsefalvay/vaers-outcomes huggingface dataset:
PAIN; INFLAMMATION; TINGLING; NUMBNESS; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the patient experienced pain, inflammation, tingling, and numbness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from pain, and the outcome of tingling, numbness and inflammation was not reported. This report was non-serious.
Patient started having chest pain approximately 20 minutes after vaccine given.  Patient was in car.  Reported that she had a stress test in the AM today prior to vaccine.  Hx of AMI.  Patient took 1 SL NTG tablet at 1245, no relief, had syncopal episode at 1248.  Patient was lowered to the ground and became A&O X 3.  Patient took another SL NTG at 1251.  EMS arrived and transported patient to hospital ED.  No follow-up information available.
site soreness (started within 3 hours of injection and is still sore 2 days later) , sleep disturbance night of injection,  elevated temp of 100deg  (started at 0200 on the 6th and lasted for 24 hours), whole body aches esp neck and back pain (Started when temp started and has lasted after temp has stopped for a total of 31 hours). Migraine with sensitivity to light (started at 0400 on the 6th and lasted for 5 hours). Nausea and heartburn (started on the 6th at 1845 lasting 5 hours despite taking famotidine)
3/29 Monday, received the vaccine and the next day, 3/30 Tuesday had only a sore arm. 3/31 to 4/6 patient progressively felt worse. Started with general body aches and progressed to worse body aches, shakes, and low grade fever, up to 99.5 F, which patient reports as a fever for her. Tuesday 4/6, go to urgent care for covid test, and tested negative (rapid and PCR). Monday, 4/12 went to PCP and to rheumatologist, they confirmed lymphedema had progressed to cellulitis, especially with increase in inflammation. 4/13 patient went to ER. Started vancomycin IV, broke out in hives. Remained on vanco until 4/17, then discharged from hospital. Woke up in middle of night 4/17-4/18, could not breathe, went back to hospital. When discharged, sent home with doxycline that was finished 4/25.
MOTHER CHECKED ON CHILD AT 4:30 AM CHILD WAS AWAKE AND COMPLAINING OF BODY ACHES. MOTHER SAID CHILD WAS VERY HOT TO THE TOUCH, TOOK CHILD INTO HER BED AND AROUND 5:20AM CHILD STARTED HAVING A SEIZURE. 911 WAS CALLED AND EMS ARRIVED TOOK TEMP. IT WAS 105 F. EMS ADMINISTERED IV FLUIDS AND ALSO IBUPROFEN. CHILD WAS TAKEN TO HOSPITAL AND OBSERVED UNTIL TEMPERATURE WAS WITHIN NORMAL LIMITS THEN RELEASED AND MOTHER WAS TOLD TO OBSERVE PATIENT AND TO NOTIFY PEDIATRICIAN.
PATIENT WAS ADMINISTERED CHILD DOSAGE(5-11YRS OLD) INSTEAD OF 12+ DOSAGE. PATIENT SHOWED NO LIFE THREATENING SYMPTOMS AFTER SHOT ADMINISTERED & THROUGHOUT THE 15 MINUTE OBSERVATION PERIOD.
Aprrox 5 minutes after getting the vaccine started to feel dizzy and light headed.  I passed out for a couple minutes.  Approx 10 minutes later I felt fine.  Don't know if it was a reaction to the vaccine or the fact that I don't like shots all that well, but I was told to report it.  This has happened before when I have gotten a shot but it doesn't always happen.  I would say its 50/50
t102; c/o fever, itching, SOB; mom says had pt to breathe into paper bag which relieved breathing problems; has MD appt today; MD said bronchitis;
Information has been received from a 67 year old female with no known drug reactions or allergies who on 31-JAN-2008 was vaccinated with ZOSTAVAX. Concomitant therapy included PROZAC and vitamins (unspecified). On 02-FEB-2008 the patient developed redness, pain and swelling at the injection site. Unspecified medical attention was sought. There was no product quality complaint. There were no lab diagnostic studies performed. At the time of reporting the patient had not yet recovered. Additional information has been requested.
I developed a cold sore on my lip about 4 days after my vaccine. I did not seek any medical care nor was I prescribed any medication. After about 7 days it went away on it's own.
After approximately 72 hours after injection I  had an increase in arthritic discomfort in joints of both hands
Why would i get a black eye from my second  dose; This spontaneous case was reported by a consumer and describes the occurrence of EYE CONTUSION (Why would i get a black eye from my second  dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse reaction.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jun-2021, the patient experienced EYE CONTUSION (Why would i get a black eye from my second  dose). At the time of the report, EYE CONTUSION (Why would i get a black eye from my second  dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided. No treatment was reported
Case was hospitalized for Covid 5 months after completion of primary Covid vaccine series. * Pneumonia due to COVID-19 virus Assessment & Plan Breakthrough infection; completed Moderna vaccine series in April. However is immunocompromised due to chemotherapy. O2 needs have improved somewhat since admission. She was discharged with supplemental oxygen and instructions for weaning off it. She was treated with dexamethasone and remdesivir and will complete a 10 day course of the former on 10/19. Date of symptom onset: 10/6 Date of positive test: 10/10 Duration isolation needed: 20 days Date isolation can be discontinued: 10/26
pt recvd vax; pt devel tenderness & pain w/in 1 hr of injection site; limited range of motion; tenderness L axilla;
On 10/02/2022 at 11:00AM, I was sent home from work because I wasn't feeling well. I had extremely high fever. I went to my doctor's office at around 3:00PM on the same day. I had a fever of 100.00. My doctor prescribed me with antibiotics for 4-5 days. He wasn't sure what was happening with me. He advised me to contact him if my fever gets worse. I also took BENADRYL for 2 nights seems like its working.
Allergic Reaction; Tongue and throat swelled; Tongue and throat swelled; Feeling odd; Shortness of breath/not breathing as normal; This spontaneous case was reported by a patient and describes the occurrence of HYPERSENSITIVITY (Allergic Reaction), SWOLLEN TONGUE (Tongue and throat swelled) and PHARYNGEAL SWELLING (Tongue and throat swelled) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. B04021A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     NO medical history was reported by reporter.  Concomitant products included THIAMINE (VITAMIN B1 [THIAMINE]) for an unknown indication.    On 03-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Jul-2021, the patient experienced HYPERSENSITIVITY (Allergic Reaction) (seriousness criterion hospitalization), SWOLLEN TONGUE (Tongue and throat swelled) (seriousness criterion hospitalization) and PHARYNGEAL SWELLING (Tongue and throat swelled) (seriousness criterion hospitalization). On an unknown date, the patient experienced FEELING ABNORMAL (Feeling odd) and DYSPNOEA (Shortness of breath/not breathing as normal). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, HYPERSENSITIVITY (Allergic Reaction), SWOLLEN TONGUE (Tongue and throat swelled), PHARYNGEAL SWELLING (Tongue and throat swelled) and FEELING ABNORMAL (Feeling odd) outcome was unknown and DYSPNOEA (Shortness of breath/not breathing as normal) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Jul-2021, Blood pressure measurement: 147 (High) Blood pressure 147 high.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient was suffered with Shortness of breath ,  feeling better. patient  doesn't have a main doctor but provides information of the hospital and Doctor that treat his allergic reaction after taking the vaccine, gives consent to safety follow up.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
patient who was administered the first dose of the Pfizer covid vaccine and 2 weeks later tested positive for covid; patient who was administered the first dose of the Pfizer covid vaccine and 2 weeks later tested positive for covid; This is a spontaneous report from a contactable other health care professional. A 57-year-old female patient received BNT162B2 (COMIRNATY, PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection, (Batch/Lot number was not reported), dose 1 via an unspecified route of administration on Jan2021 as SINGLE DOSE for covid-19 immunization. Patient medical history and concomitant medications were not reported. It was reported that, the patient who was administered the first dose of the pfizer covid vaccine and tested positive for covid, two weeks later . Caller questioned about the guidance for administering second dose,  as it was 28 days post the first dose as of now. The patient underwent lab tests and procedures which included sars-cov-2 test: positive. The outcome for the event was unknown.  Information on the lot/batch number has been requested.  Follow-up attempts are completed. No further information is expected.; Sender's Comments: Based on the information currently available, a lack of efficacy with BNT162B2  vaccine in this patient cannot be completely excluded
Hypertension; Blood pressure is up and down; This is a spontaneous report from a contactable nurse (sister). A female patient of an unspecified age received bnt162b2, via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as 2nd dose, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Patient has hypertension now. She is on medication now because of the hypertension. Patient called her doctor again and her cardiologist. Blood pressure is up and down. She has been put on statins and beta blockers. When she sits up her blood pressure goes up. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
Sore arm, could not lie on her right side, hurt; Very painful; This non-serious case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 77-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   In JAN-2023, the patient received the 1st dose of Shingrix (right arm). On an unknown date, an unknown time after receiving Shingrix, the patient experienced pain in arm (Verbatim: Sore arm, could not lie on her right side, hurt) and pain (Verbatim: Very painful). The outcome of the pain in arm and pain were resolved (duration 3 days).   It was unknown if the reporter considered the pain in arm and pain to be related to Shingrix.     It was unknown if the company considered the pain in arm and pain to be related to Shingrix.   Linked case(s) involving the same patient:  US2023AMR046600   Additional Information: GSK Receipt Date: 27-MAR-2023 The reporter was a patient who reported that she received her 1st dose of Shingrix approximately 2 months prior to 20-MAR-2023 (she did not had the exact date), and it was very painful, her right arm was so sore that she could not lie on her right side, and her right arm hurt for 2 to 3 days after receiving the shot.  For tolerance of 2nd dose refer case US2023AMR046600. The reporter consented to follow up.; Sender's Comments:  US-GSK-US2023AMR046600:Same reporter
This case was reported by a consumer via call center representative and described the occurrence of headache in a 69-year-old female patient who received SHINGRIX for prophylaxis. On 31st January 2019, the patient received SHINGRIX (intramuscular). On an unknown date, less than a week after receiving SHINGRIX, the patient experienced headache, injection site pain, injection site numbness and nerve pain. On an unknown date, the outcome of the headache, injection site pain and nerve pain were recovered/resolved and the outcome of the injection site numbness was unknown. It was unknown if the reporter considered the headache, injection site pain, injection site numbness and nerve pain to be related to SHINGRIX. Additional details were provided as follows: The patient experienced soreness and pain at injection site arm, nerve pain, headache with resolution in 1 day. The patient also experienced numbness in vaccination arm. The call was transferred to Risk Compliance.
Dizziness (had this response to 1st dose Pfizer), laid down on cot - vitals normal. Monitored and vital rechecked after sitting up - normal. Mother was with this Attendee. Mom and Attendee Left site about 10AM PDT.
This patient was vaccinated with COVID dose # 1 of Moderna on March 17, 2021. He was then vaccinated with COVID dose #2 of Moderna on April 2, 2021- 2 weeks early. The patient has had no adverse reaction to date. He was contacted by ID and Primary care Physicians. The plan is to evaluate vaccine efficacy per the patient's primary care provider and the patient at the patient's next PCP visit.
started w/low grade fever 23FEB96;APAP given t103.6 7PM w/tepid bath & APAP but started to tremble & was brought to ER;started to convuls w/twitching of face, started to moan, gen tonic clonic convuls last 3-5mins
Pt recv vax on 10/8/98; on 10/9/98 pt exp puffy eyes, hives & red welts to face &torso for 3 day.
Patient presented to the ED and was subsequently hospitalized for Atrial flutter with rapid ventricular response within 6 weeks of receiving COVID vaccination.
On 12/8/00, pt experienced local erythema and induration at site of injection. Addtl info is not expected. Pt had recvd first dose of pneumococcal vaccine 23 polyvalent on 10/20/99.
Client arrived to the vaccine POD for Pfizer booster. The client stated that she had lost vaccination card. The MA assessed client to get information for system search. After system search, MA made the client a new card with previous doses as well as dose she would receive today. MA gave client back her card. This nurse then went over the questions with client to be sure she could receive todays dose but did not check the clients card to double check previous vaccination dates. Clients previous vaccination dates are 6-7-2021 and 6-28-2021. The client received her pfizer booster today which was 8 days too early. This information was explained to the client when the error was identified and she verbalized understan
"Big hard red bump" on right thigh. At time of visit on 1 Mar, pt had 5.25 x 3.5cm area of erythema & induration, no tenderness, with some surrounding erythema.
Feeling sick; Headache; Fatigue; Inappropriate Schedule of vaccine administered; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Feeling sick), HEADACHE (Headache), FATIGUE (Fatigue) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate Schedule of vaccine administered) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) injection for Rheumatoid arthritis.    No Medical History information was reported.   On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In 2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. In 2021, the patient experienced MALAISE (Feeling sick), HEADACHE (Headache), FATIGUE (Fatigue) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate Schedule of vaccine administered). At the time of the report, MALAISE (Feeling sick), HEADACHE (Headache) and FATIGUE (Fatigue) had not resolved and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate Schedule of vaccine administered) outcome was unknown.            This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in. No concomitant medication was reported. No treatment medication was reported. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. It was reported that Humira daily dose was citrate free.   This case was linked to MOD-2021-623538 (Patient Link).
After Covid 19 vaccine administration, the patient felt light-headed and nauseated then fainted. She came about after a minute and could not stand up right after the shot. She needed to rest for a while before moving to an observation chair where we kept her comfortable for 30 minutes before she left.
Nausea, diarrhea, weakness, shakiness with no known cause, still not completely resolved 1.5 weeks later. (Rest/rehydration fluids)  Unsure if it is the vaccine for sure, but my mother had similar symptoms about 3 weeks after her second shot of an mRNA covid vaccine, along with tachycardia. So it?s suspicious.
Menstrual changes - period is very regular and came 1 week early, then have been spotting ever since General body aches, sore throat and sinus symptoms on and off
I had my second shot at 5/6/21 at 5pm. About 23 hours later (5/7 at 4pm) I suddenly felt tired and then about 24 hours after the shot, I felt utter exhaustion.  About 25 hours after the shot (5/7 6pm), I had chills/severe shivering and body aches that lasted for approximately 6 or 7 hours. The exhaustion lasted in total about 36-40 hours.
Severe head ache, intense joint pain throughout entire body, exhaustion. Then shortness of breath that started around 4pm and lasted until about 7pm.
Perpetual Assessment: Patient is a 88 y.o. male h/o COPD (3L NC), CHF, CAD who presented from home on 3/8/2023 with sob, abd pain, diarrhea and weakness who was positive for COVID in the ED.         Assessment and Plan Cardiorespiratory Arrest - Developed this in ER, due to below - Code status confirmed to be DNR CCA, DNI with patient and family prior to arrest. Patient expired at 1545.   COPD Exacerbation Acute on Chronic respiratory failure Possible Sepsis/Pneumonia - Possible early pneumonia seen on CXR (atelectasis vs infiltrate) - Hypoxic 70's on presentation, placed on Non-rebreather with improvement - Given iv steroids, iv fluids with improvement in hemodynamics   Diarrhea Dehydration - Most likely ischemic colitis given hypotension on presentation to ER - CT A/P showed concern by "bowel obstruction" and general surgery team was consulted by ER MD   Medication Reconciliation: Reviewed   DVT Prophylaxis: Lovenox   Code Status: DNR CCA, DNI (confirmed with patient and family)   Expected date of discharge: patient deceased in ER
CLIENT RECEIVED PEDIATRIC PFIZER FORMULATION OF 0.2ML AT 12YO. 12YO AND ABOVE RECEIVE GRAY CAP FORMULATION OF 0.3ML
The morning after my vaccination my right thumb turned purple/black from the joint to the tip along with feelings of pins and needles that come and go.; The morning after my vaccination my right thumb turned purple/black from the joint to the tip along with feelings of pins and needles that come and go.; This is a spontaneous report from a contactable consumer, the patient. A 76-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: EW0150) via an unspecified route of administration in the left arm on 08Apr2021 at 11:00 (at the age of 76-year-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. Concomitant medications included calcium carbonate, magnesium carbonate (TUMS) and acetylsalicylic acid, ascorbic acid (ASPIRIN), all for unknown indication from an unknown date. Allergies to medications, food, or other products was reported as unknown. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 06:00, the morning after the vaccination patient's right thumb turned purple/black from the joint to the tip along with feelings of pins and needles that come and go. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events right thumb turned purple/black from the joint to the tip along with feelings of pins and needles that come and go was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
I had a severe headache especially in the back of the eyes; nauseated; body aches, lower back pain; felt like a truck ran over me. They lasted about 18-19 hours after initial start. The recent health event, I have been fighting lower back pain since end of May and have been going to PT, started that the end of July and went got an MRI (had that the 17th or so of July), stuff going on in my lower back with diagnosis of Spinal Stenosis. Continued PT and went off a lot of anti-inflammatories (Meloxicam is when I got on that August 15 or 16, and previous to that was taking ibuprofen) went to ice/heat and taking ibuprofen as needed and that was September 15th. It seemed to help to get off of those as far as helping the GERDS symptoms. I had gotten really bad GERDS and nausea and so they told me to get off of those. My symptoms have improved but I still have the lower back pain. My anxiety also had gone up, it's seems to have gone up.
Body ache; Vomiting; Fever; Fatigue; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body ache), VOMITING (Vomiting), PYREXIA (Fever), FATIGUE (Fatigue) and CHILLS (Chills) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Crohn's disease and Osteoarthritis.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (Body ache), VOMITING (Vomiting), PYREXIA (Fever), FATIGUE (Fatigue) and CHILLS (Chills). At the time of the report, PAIN (Body ache), VOMITING (Vomiting), PYREXIA (Fever), FATIGUE (Fatigue) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
p/vax pt was pale; had stomach pain; pulse 100; was very ashen; pulse 60; BP 90/20; p/ 9:50am pulse 68, BP 100/60, color still bad but was talking to nurse; 10:10am BP110/66; BP 100/90;
Client c/o L deltoid pain. Deltoid is swollen. red, hot to touch. She is very mobile, was playing with other children. RN recommended children's Motrin & cold compresses.